| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 9,087,000 | 10,899,000 | 15,411,000 | 16,380,000 | | Cost of Revenue | 8,165,000 | 10,493,000 | 13,975,000 | 14,643,000 | | | Gross Profit | 922,000 | 406,000 | 1,436,000 | 1,737,000 | | | Operating Expenses | | Research Development | 292,000 | 310,000 | 334,000 | 335,000 | | Selling General and Administrative | 444,000 | 458,000 | 498,000 | 515,000 | | Non Recurring | 67,000 | 1,072,000 | 45,000 |
-
| | Others | 22,000 | 24,000 | 21,000 | 25,000 | | | | Total Operating Expenses | 825,000 | 1,864,000 | 898,000 |
-
| | | | Operating Income or Loss | 97,000 | (1,458,000) | 538,000 | 862,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9,000 | 54,000 | (11,000) | 62,000 | | Earnings Before Interest And Taxes | 171,000 | (1,408,000) | 793,000 | 1,175,000 | | Interest Expense | 154,000 | 192,000 | 160,000 | 151,000 | | Income Before Tax | 17,000 | (1,600,000) | 633,000 | 1,024,000 | | Income Tax Expense | (18,000) | (60,000) | 185,000 | 243,000 | | Minority Interest |
-
| (12,000) | (20,000) | (19,000) | | | | Net Income From Continuing Ops | 35,000 | (1,552,000) | 428,000 | 762,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 35,000 | (1,552,000) | 428,000 | 762,000 | | Preferred Stock And Other Adjustments | (11,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $24,000 | ($1,552,000) | $428,000 | $762,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
